Recombinant human anti-TNFα monoclonal antibody (Taizhou Mabtech)

重组抗TNFα全人源单抗（泰州迈博太科药业）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human anti-TNFα monoclonal antibody (Taizhou Mabtech)
Drug Alias Name重组抗TNFα全人源单克隆（泰州迈博太科药业）
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesTaizhou Maibo Taike Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaizhou Mabtech Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A